Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02007005
Recruitment Status : Completed
First Posted : December 10, 2013
Last Update Posted : May 6, 2015
Information provided by (Responsible Party):
Abnoba Gmbh